Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment has been made of the adequacy of treatment provisions for people diagnosed with advanced-stage of mycosis fungoides and Sézary syndrome, two subtypes of Cutaneous T-Cell Lymphoma.
Cancer Alliances have pathways in place to support diagnosis of T-cell lymphomas as part of their skin cancer pathways. No recent assessment on Sézary syndrome or Mycosis Fungoides has been made. However, the National Institute for Health and Care Excellence is due to publish guidance on the use of mogamulizumab for previously treated mycosis fungoides and Sézary syndrome at the end of March 2021.